Life Sciences and Information Technology Companies Join EndPandemic National Data Consortium to Integrate COVID-19 Clinical Data

Published on: 

Applied Clinical Trials

The EndPandemic National Data Consortium has announced that it has received commitments from six life sciences and information technology companies to join the Consortium. The companies will work together toward the goal of integrating data from all ongoing and future clinical studies to accelerate analysis on COVID-19 and SARS-CoV-2 research in order to reduce the time to find a cure by up to 50%.

For more information, click here.